AZN logo

AstraZeneca PLC (AZN) Cash From Investing

Annual CFI:

-$7.98B-$3.92B(-96.36%)
December 31, 2024

Summary

  • As of today, AZN annual cash from investing is -$7.98 billion, with the most recent change of -$3.92 billion (-96.36%) on December 31, 2024.
  • During the last 3 years, AZN annual cash from investing has risen by +$3.08 billion (+27.84%).
  • AZN annual cash from investing is now -922.68% below its all-time high of $970.00 million, reached on December 31, 2004.

Performance

AZN Cash From Investing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherAZNcash flow metrics

Quarterly CFI:

-$2.20B-$881.01M(-66.74%)
June 30, 2025

Summary

  • As of today, AZN quarterly cash from investing is -$2.20 billion, with the most recent change of -$881.01 million (-66.74%) on June 30, 2025.
  • Over the past year, AZN quarterly cash from investing has increased by +$783.99 million (+26.26%).
  • AZN quarterly cash from investing is now -222.47% below its all-time high of $1.80 billion, reached on June 30, 2006.

Performance

AZN Quarterly Cash From Investing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherAZNcash flow metrics

TTM CFI:

-$6.35B+$783.99M(+10.98%)
June 30, 2025

Summary

  • As of today, AZN TTM cash from investing is -$6.35 billion, with the most recent change of +$783.99 million (+10.98%) on June 30, 2025.
  • Over the past year, AZN TTM cash from investing has increased by +$1.59 billion (+20.01%).
  • AZN TTM cash from investing is now -525.05% below its all-time high of $1.49 billion, reached on June 30, 2005.

Performance

AZN TTM Cash From Investing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherAZNcash flow metrics

Cash From Investing Formula

CFI = Cash Inflows from Investments − Cash Outflows for Investments

AZN Cash From Investing Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1Y1 Year-96.4%+26.3%+20.0%
3Y3 Years+27.8%-172.7%+49.2%
5Y5 Years-1114.6%-1683.5%-1394.8%

AZN Cash From Investing Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs LowTTM vs HighTTM vs HighTTM vs LowTTM vs Low
3Y3-Year-169.6%+27.8%-677.7%+26.3%-110.4%+23.7%
5Y5-Year-2700.0%+27.8%-514.5%+79.0%-3014.2%+49.2%
All-TimeAll-Time-922.7%+46.4%-222.5%+84.3%-525.0%+63.7%

AZN Cash From Investing History

DateAnnualQuarterlyTTM
Jun 2025
-
-$2.20B(-66.7%)
-$6.35B(+11.0%)
Mar 2025
-
-$1.32B(-6.2%)
-$7.14B(+14.2%)
Dec 2024
-$7.98B(-96.4%)
-$1.24B(+21.8%)
-$8.32B(-1.1%)
Sep 2024
-
-$1.59B(+46.8%)
-$8.24B(-3.7%)
Jun 2024
-
-$2.98B(-19.1%)
-$7.94B(-43.3%)
Mar 2024
-
-$2.51B(-116.8%)
-$5.54B(-27.4%)
Dec 2023
-$4.06B(-37.3%)
-$1.16B(+10.7%)
-$4.35B(-25.1%)
Sep 2023
-
-$1.29B(-120.6%)
-$3.48B(+11.8%)
Jun 2023
-
-$587.00M(+55.3%)
-$3.94B(+5.3%)
Mar 2023
-
-$1.31B(-364.0%)
-$4.16B(-37.8%)
Dec 2022
-$2.96B(+73.2%)
-$283.00M(+83.9%)
-$3.02B(+20.6%)
Sep 2022
-
-$1.76B(-118.0%)
-$3.81B(+69.6%)
Jun 2022
-
-$807.00M(-371.9%)
-$12.51B(-4.8%)
Mar 2022
-
-$171.00M(+84.0%)
-$11.94B(-6.2%)
Dec 2021
-$11.06B(-3780.0%)
-$1.07B(+89.8%)
-$11.24B(-12.0%)
Sep 2021
-
-$10.46B(-4278.7%)
-$10.04B(-6174.4%)
Jun 2021
-
-$239.00M(-145.0%)
-$160.00M(-173.4%)
Mar 2021
-
$531.00M(+296.3%)
$218.00M(+165.7%)
Dec 2020
-$285.00M(+56.6%)
$134.00M(+122.9%)
-$332.00M(+21.9%)
Sep 2020
-
-$586.00M(-521.6%)
-$425.00M(-312.5%)
Jun 2020
-
$139.00M(+831.6%)
$200.00M(+118.3%)
Mar 2020
-
-$19.00M(-146.3%)
-$1.09B(-39.8%)
Dec 2019
-$657.00M(-168.2%)
$41.00M(+5.1%)
-$781.00M(-1339.7%)
Sep 2019
-
$39.00M(+103.4%)
$63.00M(+142.9%)
Jun 2019
-
-$1.15B(-494.9%)
-$147.00M(-117.9%)
Mar 2019
-
$292.00M(-67.0%)
$822.00M(+6.8%)
Dec 2018
$963.00M(+141.4%)
$885.00M(+617.5%)
$770.00M(+142.7%)
Sep 2018
-
-$171.00M(+7.1%)
-$1.80B(+10.3%)
Jun 2018
-
-$184.00M(-176.7%)
-$2.01B(+2.5%)
Mar 2018
-
$240.00M(+114.2%)
-$2.06B(+17.3%)
Dec 2017
-$2.33B(+41.3%)
-$1.69B(-346.6%)
-$2.49B(-955.9%)
Sep 2017
-
-$378.00M(-60.9%)
-$236.00M(+55.0%)
Jun 2017
-
-$235.00M(-23.0%)
-$524.00M(+61.8%)
Mar 2017
-
-$191.00M(-133.6%)
-$1.37B(+66.6%)
Dec 2016
-$3.97B(+6.4%)
$568.00M(+185.3%)
-$4.11B(+43.6%)
Sep 2016
-
-$666.00M(+38.4%)
-$7.28B(-2.9%)
Jun 2016
-
-$1.08B(+63.1%)
-$7.08B(-5.8%)
Mar 2016
-
-$2.93B(-12.4%)
-$6.70B(-53.5%)
Dec 2015
-$4.24B(+39.7%)
-$2.61B(-462.9%)
-$4.36B(-31.2%)
Sep 2015
-
-$463.00M(+33.6%)
-$3.32B(+3.7%)
Jun 2015
-
-$697.00M(-16.9%)
-$3.45B(+12.9%)
Mar 2015
-
-$596.00M(+62.0%)
-$3.96B(+44.8%)
Dec 2014
-$7.03B(-143.4%)
-$1.57B(-165.2%)
-$7.17B(-8.1%)
Sep 2014
-
-$591.00M(+51.0%)
-$6.64B(+1.3%)
Jun 2014
-
-$1.21B(+68.3%)
-$6.73B(-4.9%)
Mar 2014
-
-$3.81B(-268.6%)
-$6.41B(-114.6%)
Dec 2013
-$2.89B(-55.4%)
-$1.03B(-51.7%)
-$2.99B(-18.7%)
Sep 2013
-
-$680.78M(+23.7%)
-$2.52B(+44.8%)
Jun 2013
-
-$892.47M(-133.4%)
-$4.56B(-55.3%)
Mar 2013
-
-$382.43M(+32.0%)
-$2.93B(-45.9%)
Dec 2012
-$1.86B(+8.1%)
-$562.21M(+79.3%)
-$2.01B(+60.3%)
Sep 2012
-
-$2.72B(-472.0%)
-$5.07B(-351.7%)
Jun 2012
-
$731.31M(+35.3%)
-$1.12B(+34.2%)
Mar 2012
-
$540.32M(+114.9%)
-$1.71B(+22.1%)
Dec 2011
-$2.02B
-$3.62B(-395.0%)
-$2.19B(-341.8%)
Sep 2011
-
$1.23B(+725.9%)
$905.59M(+826.9%)
DateAnnualQuarterlyTTM
Jun 2011
-
$148.63M(+166.8%)
-$124.58M(+89.6%)
Mar 2011
-
$55.71M(+110.6%)
-$1.19B(+52.5%)
Dec 2010
-$2.23B(+10.1%)
-$526.29M(-366.6%)
-$2.52B(+35.7%)
Sep 2010
-
$197.37M(+121.4%)
-$3.91B(+14.3%)
Jun 2010
-
-$921.71M(+27.2%)
-$4.57B(-17.4%)
Mar 2010
-
-$1.27B(+34.1%)
-$3.89B(-51.2%)
Dec 2009
-$2.48B(+36.4%)
-$1.92B(-322.0%)
-$2.57B(-113.3%)
Sep 2009
-
-$455.55M(-85.7%)
-$1.21B(-20.1%)
Jun 2009
-
-$245.37M(-591.5%)
-$1.00B(+3.8%)
Mar 2009
-
$49.92M(+109.0%)
-$1.04B(+74.4%)
Dec 2008
-$3.90B(+73.8%)
-$555.42M(-119.3%)
-$4.08B(-1.4%)
Sep 2008
-
-$253.31M(+11.1%)
-$4.02B(-5.6%)
Jun 2008
-
-$284.90M(+90.5%)
-$3.81B(+78.2%)
Mar 2008
-
-$2.99B(-498.5%)
-$17.50B(-14.8%)
Dec 2007
-$14.89B(-5373.2%)
-$499.00M(-1117.1%)
-$15.24B(-4.7%)
Sep 2007
-
-$41.00M(+99.7%)
-$14.55B(+4.0%)
Jun 2007
-
-$13.98B(-1817.1%)
-$15.17B(-2594.2%)
Mar 2007
-
-$729.00M(-479.7%)
$608.03M(+197.4%)
Dec 2006
-$272.00M(+77.0%)
$192.00M(+129.4%)
-$624.00M(+56.9%)
Sep 2006
-
-$652.22M(-136.3%)
-$1.45B(+28.8%)
Jun 2006
-
$1.80B(+191.6%)
-$2.03B(+38.8%)
Mar 2006
-
-$1.96B(-211.1%)
-$3.32B(-139.2%)
Dec 2005
-$1.18B(-221.9%)
-$630.35M(+49.1%)
-$1.39B(-257.2%)
Sep 2005
-
-$1.24B(-342.8%)
$883.22M(-40.9%)
Jun 2005
-
$509.67M(+1822.4%)
$1.49B(+4.7%)
Mar 2005
-
-$29.59M(-101.8%)
$1.43B(+69.0%)
Dec 2004
$970.00M(+213.8%)
$1.64B(+362.0%)
$845.00M(+160.8%)
Sep 2004
-
-$626.31M(-241.3%)
-$1.39B(-27.9%)
Jun 2004
-
$443.23M(+172.3%)
-$1.09B(+39.3%)
Mar 2004
-
-$612.79M(-3.2%)
-$1.79B(-18.0%)
Dec 2003
-$852.00M(+44.8%)
-$593.97M(-83.8%)
-$1.52B(-5.9%)
Sep 2003
-
-$323.21M(-24.5%)
-$1.43B(+5.2%)
Jun 2003
-
-$259.68M(+23.7%)
-$1.51B(+5.4%)
Mar 2003
-
-$340.13M(+33.3%)
-$1.60B(-3.6%)
Dec 2002
-$1.54B(+2.8%)
-$509.94M(-26.8%)
-$1.54B(+2.8%)
Sep 2002
-
-$402.17M(-16.3%)
-$1.59B(+1.1%)
Jun 2002
-
-$345.89M(-21.4%)
-$1.60B(-6.2%)
Mar 2002
-
-$285.00M(+48.6%)
-$1.51B(+4.8%)
Dec 2001
-$1.59B(-22.7%)
-$554.28M(-32.2%)
-$1.59B(-19.6%)
Sep 2001
-
-$419.33M(-66.2%)
-$1.33B(+31.4%)
Jun 2001
-
-$252.28M(+30.1%)
-$1.93B(-42.3%)
Mar 2001
-
-$361.11M(-22.7%)
-$1.36B(-5.1%)
Dec 2000
-$1.29B(-71.8%)
-$294.29M(+71.3%)
-$1.29B(-29.5%)
Sep 2000
-
-$1.03B(-418.4%)
-$999.17M(-3668.0%)
Jun 2000
-
$322.62M(+209.5%)
$28.00M(+109.5%)
Mar 2000
-
-$294.62M
-$294.62M
Dec 1999
-$753.00M(+77.7%)
-
-
Dec 1998
-$3.38B(-489.6%)
-
-
Dec 1997
-$573.63M(-4.7%)
-
-
Dec 1996
-$548.00M(+15.6%)
-
-
Dec 1995
-$648.99M(-44.1%)
-
-
Dec 1994
-$450.26M(-15.7%)
-
-
Dec 1993
-$389.03M(-45.7%)
-
-
Dec 1992
-$266.94M(-30.9%)
-
-
Dec 1991
-$203.96M(-211.0%)
-
-
Dec 1990
-$65.58M
-
-

FAQ

  • What is AstraZeneca PLC annual cash from investing?
  • What is the all-time high annual cash from investing for AstraZeneca PLC?
  • What is AstraZeneca PLC annual cash from investing year-on-year change?
  • What is AstraZeneca PLC quarterly cash from investing?
  • What is the all-time high quarterly cash from investing for AstraZeneca PLC?
  • What is AstraZeneca PLC quarterly cash from investing year-on-year change?
  • What is AstraZeneca PLC TTM cash from investing?
  • What is the all-time high TTM cash from investing for AstraZeneca PLC?
  • What is AstraZeneca PLC TTM cash from investing year-on-year change?

What is AstraZeneca PLC annual cash from investing?

The current annual cash from investing of AZN is -$7.98B

What is the all-time high annual cash from investing for AstraZeneca PLC?

AstraZeneca PLC all-time high annual cash from investing is $970.00M

What is AstraZeneca PLC annual cash from investing year-on-year change?

Over the past year, AZN annual cash from investing has changed by -$3.92B (-96.36%)

What is AstraZeneca PLC quarterly cash from investing?

The current quarterly cash from investing of AZN is -$2.20B

What is the all-time high quarterly cash from investing for AstraZeneca PLC?

AstraZeneca PLC all-time high quarterly cash from investing is $1.80B

What is AstraZeneca PLC quarterly cash from investing year-on-year change?

Over the past year, AZN quarterly cash from investing has changed by +$783.99M (+26.26%)

What is AstraZeneca PLC TTM cash from investing?

The current TTM cash from investing of AZN is -$6.35B

What is the all-time high TTM cash from investing for AstraZeneca PLC?

AstraZeneca PLC all-time high TTM cash from investing is $1.49B

What is AstraZeneca PLC TTM cash from investing year-on-year change?

Over the past year, AZN TTM cash from investing has changed by +$1.59B (+20.01%)
On this page